18.48 USD
+0.58 (+3.24%)
18.48 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 80% to TBPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 21.25. This target is 14.99% above the current price.
TBPH was analyzed by 12 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about TBPH.
In the previous month the buy percentage consensus was at a similar level.
TBPH was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-12 | B. Riley Securities | Initiate | Buy |
| 2025-06-27 | BTIG | Maintains | Buy -> Buy |
| 2025-06-17 | Jones Trading | Initiate | Buy |
| 2025-02-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-06 | Leerink Partners | Downgrade | Outperform -> Market Perform |
| 2024-08-06 | TD Cowen | Maintains | Hold -> Hold |
| 2024-08-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-05-29 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-12 | BTIG | Initiate | Buy |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-09 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-28 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-11-17 | SVB Leerink | Maintains | Outperform |
| 2022-11-08 | HC Wainwright & Co. | Maintains | Buy |
| 2022-07-25 | Morgan Stanley | Maintains | Underweight |
| 2022-05-23 | SVB Leerink | Initiate | Outperform |
| 2022-03-02 | Morgan Stanley | Maintains | Underweight |
| 2022-02-24 | HC Wainwright & Co. | Maintains | Buy |
| 2021-11-05 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2021-09-16 | SVB Leerink | Maintains | Outperform |
| 2021-09-16 | Morgan Stanley | Maintains | Underweight |
| 2021-09-16 | HC Wainwright & Co. | Maintains | Buy |
| 2021-08-25 | Morgan Stanley | Downgrade | Overweight -> Underweight |
| 2021-08-24 | Needham | Maintains | Buy |
| 2021-08-24 | SVB Leerink | Maintains | Outperform |
| 2021-08-24 | Cowen & Co. | Downgrade | Outperform -> Market Perform |
THERAVANCE BIOPHARMA INC / TBPH FAQ
Can you provide the average price target for THERAVANCE BIOPHARMA INC stock?
12 analysts have analysed TBPH and the average price target is 21.25 USD. This implies a price increase of 14.99% is expected in the next year compared to the current price of 18.48.
How do analysts rate THERAVANCE BIOPHARMA INC (TBPH)?
The consensus rating for THERAVANCE BIOPHARMA INC (TBPH) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.